Cephalexin
Sold as Ceporex, Cephalexin pharma q, Cephalexin dry pharma-q, Aspen-cephalexin 125p, Aspen-cephalexin 250p, Aspen-cephalexin, Ranceph, Belex, Bactocep, Cefalexin alkem, Cefalexin resmed, Xenara, Rilexine, Keflex, Keflex p, Lenocef
(6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 27447.
Background
Registration
- Applicants
- 10
- Registrations
- 32
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Intervet South Africa (Pty) Ltd2 of 3 cancelled | Ceporex | 50 mg, oral drops, injection | 02-14, 83/568, 87/13 | Not determined | None |
| Pharma-q Holdings (Pty) Ltd | Cephalexin pharma q, Cephalexin dry pharma-q | 250, 500, syrup | 290124, 290125, 290126 | Not determined | None |
| Pharmacare limited û woodmeadCancelled | Aspen-cephalexin 125p, Aspen-cephalexin 250p, Aspen-cephalexin, Keflex, Keflex p, Lenocef | 125, 250, 500 | 290534, 290595, 300128, B0092, C0028, C0029, C0220, N0128, N0129, N0134, N0135 | Not determined | None |
| Ranbaxy (SA) (Pty) Ltd | Ranceph | 125 mg/ 5ML, 250, 250 mg/5 ML, 500 | 300334, 300335, 320214, 320215 | Not determined | None |
| Gulf Drug Company (Pty) Ltd | Belex | 250, 500 | 370617, 370618 | Not determined | None |
| Biotech Laboratories (Pty) Ltd | Bactocep | 250, 500 | 480812, 480813 | Not determined | None |
| Ascend Laboratories (Pty) Ltd | Cefalexin alkem | 250, 500 | 480814, 480815 | Not determined | None |
| Resmed healthcare | Cefalexin resmed | 125 mg, 250 mg | 530169, 530170 | S4 | PIPIL |
| Aurogen South Africa (Pty) LtdCancelled | Xenara | 125 mg/5 ml, 250 mg/5 ml | 550158.156, 550159.157 | Not determined | None |
| Logos Agvet (Pty) Ltd | Rilexine | 100 | 83/655 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Ceporex 50 MG tablets EACH TABLET CONTAINS CEPHALEXIN 50,0 mg | 50 mgTablets | 02-1402/17.1.1.2/14 | Cancelled | Not determined | None |
| Cephalexin 250 pharma q EACH CAPSULE CONTAINS CEPHALEXIN 250 mg | 250 | 29012429/20.1.1/0124 | Registered | Not determined | None |
| Cephalexin 500 pharma q EACH CAPSULE CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 500 mg CEPHALEXIN | 500 | 29012529/20.1.1/0125 | Registered | Not determined | None |
| Cephalexin dry syrup pharma-q EACH 5 ml SYRUP CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 125,0 mg ANHYDROUS CEPHALEXIN | Syrup | 29012629/20.1.1/0126 | Registered | Not determined | None |
| Aspen-cephalexin 125p EACH 5 ml SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 125 mg CEPHALEXIN | Not listed | 29053429/20.1.1/0534 | Cancelled | Not determined | None |
| Aspen-cephalexin 250p EACH 5 ml SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 250 mg CEPHALEXIN | Not listed | 29059529/20.1.1/0595 | Cancelled | Not determined | None |
| Aspen-cephalexin 250 EACH CAPSULE CONTAINS CEPHALEXIN 250 mg | 250 | 30012830/20.1.1/0128 | Cancelled | Not determined | None |
| Ranceph 250 capsules EACH CAPSULE CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 250,0 mg CEPHALEXIN | 250Capsules | 30033430/20.1.1/0334 | Registered | Not determined | None |
| Ranceph 500 capsules EACH CAPSULE CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 500,0 mg | 500Capsules | 30033530/20.1.1/0335 | Registered | Not determined | None |
| Ranceph suspension 125 mg/ 5ml EACH 5,0 ml SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 125,0 mg | 125 mg/ 5MLSuspension | 32021432/20.1.1/0214 | Registered | Not determined | None |
| Ranceph suspension 250 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 250,0 mg | 250 mg/5 MLSuspension | 32021532/20.1.1/0215 | Registered | Not determined | None |
| Belex 250 EACH TABLET CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 250,0 mg | 250 | 37061737/20.1.1/0617 | Registered | Not determined | None |
| Belex 500 EACH CAPSULE CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 500,0 mg | 500 | 37061837/20.1.1/0618 | Registered | Not determined | None |
| Bactocep 250 EACH CAPSULE CONTAINS : CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 250,0 mg | 250 | 48081248/20.1.1/0812 | Registered | Not determined | None |
| Bactocep 500 EACH CAPSULE CONTAINS : CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 500,0 mg | 500 | 48081348/20.1.1/0813 | Registered | Not determined | None |
| Cefalexin 250 alkem EACH CAPSULE CONTAINS : CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 250,0 mg | 250 | 48081448/20.1.1/0814 | Registered | Not determined | None |
| Cefalexin 500 alkem EACH CAPSULE CONTAINS : CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 500,0 mg | 500 | 48081548/20.1.1/0815 | Registered | Not determined | None |
| Cefalexin 250 capsules resmed EACH CAPSULE CONTAINS CEPHALEXIN 250,0 mg | 250 mgCapsule | 53016953/20.1.1/0169Approved 3 August 2022 | Registered | S4 | PIPIL |
| Cefalexin 125 suspension resmed EACH 5,0 ml SUSPENSION CONTAINS CEPHALEXIN 125,0 mg | 125 mgPowder for oral suspension | 53017053/20.1.1/0170Approved 26 July 2022 | Registered | S4 | PIPIL |
| Xenara oral suspension 125 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS: CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 125,0 mg | 125 mg/5 mlOral suspension | 550158.15655/20.1.1/0158.156 | Cancelled | Not determined | None |
| Xenara oral suspension 250 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS: CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 250,0 mg | 250 mg/5 mlOral suspension | 550159.15755/20.1.1/0159.157 | Cancelled | Not determined | None |
| Ceporex oral drops EACH 1 ml CONTAINS CEPHALEXIN A 100 mg | Oral drops | 83/568 | Old Medicine | Not determined | None |
| Rilexine 100 tablets EACH TABLET CONTAINS CEPHALEXIN A 100 MG | 100Tablets | 83/655 | Old Medicine | Not determined | None |
| Ceporex injection EACH 1ml INJECTION CONTAINS CEPHALEXIN SODIUM EQUIVALENT TO 180 mg CEPHALEXIN | Injection | 87/1387/21.1/13 | Cancelled | Not determined | None |
| Keflex 250 EACH CAPSULE CONTAINS CEPHALEXIN 250 mg | 250 | B0092B/20.1.1/92 | Cancelled | Not determined | None |
| Keflex 125 p EACH 5 ml SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 125 mg CEPHALEXIN | 125 | C0028C/20.1.1/28 | Cancelled | Not determined | None |
| Keflex 250 p EACH 5 ml SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 250 mg CEPHALEXIN | 250 | C0029C/20.1.1/29 | Cancelled | Not determined | None |
| Keflex 500 EACH TABLET CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 500 mg CEPHALEXIN | 500 | C0220C/20.1.1/220 | Cancelled | Not determined | None |
| Lenocef - 250 EACH CAPSULE CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 250 mg | - 250 | N0128N/20.1.1/128 | Cancelled | Not determined | None |
| Lenocef-500 EACH CAPSULE CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 500 mg CEPHALEXIN | 500 | N0129N/20.1.1/0129 | Cancelled | Not determined | None |
| Lenocef - 125 suspension EACH 5 ml RECONSTITUTED SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 125 mg CEPHALEXIN | - 125Suspension | N0134N/20.1.1/134 | Cancelled | Not determined | None |
| Lenocef-250 suspension EACH 5 ml RECONSTITUTED SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 250 mg CEPHALEXIN | 250Suspension | N0135N/20.1.1/135 | Cancelled | Not determined | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Cefalexin 250 capsules resmed, Resmed healthcare is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.